Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
CEO, Director, 10%+ Owner
-
Stock Symbol
-
BIXT on OTC
David Platt - trading volume in the past year for Bioxytran, Inc
Holdings reported by David Platt for Bioxytran, Inc
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Preferred |
19.8M |
$10.8M |
$0.55 |
Oct 25, 2024 |
Direct |
|
|
| common |
20.1M |
$2.09M |
$0.10 |
Mar 27, 2024 |
by NDPD Pharma, Inc. |
|
|
| common |
0 |
$0 |
$0.00 |
Aug 19, 2024 |
by Naomi Platt |
|
|
| common |
0 |
$0 |
$0.16 |
Aug 19, 2024 |
by NDPD Pharma |
|
|
| common |
0 |
$0 |
$0.00 |
Aug 19, 2024 |
Direct |
|
|
| Preferred |
0 |
$0 |
$0.29 |
Oct 25, 2024 |
through NDPD Pharma |
|
|
Transactions reported by David Platt for Bioxytran, Inc
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.